Long-term Outcomes of Conservative Management in Patients With Moyamoya Disease and Their First-degree Relatives (LAMORA)
Condition(s):Moyamoya DiseaseLast Updated:June 2, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Moyamoya DiseaseLast Updated:June 2, 2022Recruiting
Condition(s):Moyamoya Disease; Intracranial Atherosclerotic Stroke; Intracranial Steno-occlusive DiseaseLast Updated:April 26, 2017Unknown status
Condition(s):Moyamoya DiseaseLast Updated:December 20, 2023Recruiting
Condition(s):Moyamoya DiseaseLast Updated:March 12, 2021Completed
Condition(s):Moyamoya DiseaseLast Updated:December 5, 2016Unknown status
Condition(s):Moyamoya Disease; Remote Ischemic PreconditioningLast Updated:September 19, 2019Suspended
Condition(s):Moyamoya DiseaseLast Updated:March 10, 2021Withdrawn
Condition(s):Moyamoya DiseaseLast Updated:September 25, 2023Not yet recruiting
Condition(s):Moyamoya Disease; Gut MicrobiotaLast Updated:May 18, 2021Unknown status
Condition(s):Moyamoya DiseaseLast Updated:June 29, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.